Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-24-098052

Director sold 281,541 shares at an average $44.76 ($12,601,536)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kersten Dirk Director 2024-08-14 Sale 10b5-1 −100,650 $43.67 $4,395,386 1,553,039 I
Kersten Dirk Director 2024-08-15 Sale 10b5-1 −131,290 $45.25 $5,940,873 1,421,749 I
Kersten Dirk Director 2024-08-15 Sale 10b5-1 −49,601 $45.67 $2,265,278 1,372,148 I
Open-market sales · 281,541 sh · avg $44.76 · $12,601,536
Loading xslF345X05/ownership.xml…